ReviewViruses2025
Europe Faces Multiple Arboviral Threats in 2025.
Review in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Pediatric Arboviral Infections in Europe: Epidemiology, Clinical Features, Diagnosis and Prevention.Viruses · 2026Review
- Knowledge, risk perceptions and practices regarding mosquito-borne arboviral diseases among physicians in Baden-Wuerttemberg, Germany: A cross-sectional questionnaire-based analysis.Public health in practice (Oxford, England) · 2026Article
- Public health consequences of global climate change. A narrative review.Frontiers in cellular and infection microbiology · 2026Review
- Blood feeding, microbiota, and layered mosquito immunity: from pathway phenotypes to vector competence.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The year 2025 likely marks a turning point in both the perception and the reality of mosquito-borne arboviral diseases in Europe. While chikungunya and dengue viruses have long been regarded as tropical illnesses confined to intertropical regions, West Nile virus has circulated for decades in temperate areas, including southern Europe. Nevertheless, all three mosquito-borne viruses are now increasingly established across the European continent. This evolution reflects a profound transformation of the European epidemiological landscape, where arboviral diseases are increasingly emerging as endemic and seasonal threats. This shift concerns not only the scale but also the dynamics of transmission, with the appearance of newly affected regions, an earlier onset of the transmission season, and a broader diversity of arboviruses involved. Europe is thus entering a new phase in which longer, wider, and more intense transmission of vector-borne diseases is likely to become the new norm requiring strengthened preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.